Javascript must be enabled to continue!
Oncolytic Bacterial and Viral Therapies as Cancer Prevention and Treatment Options: A Comprehensive Review
View through CrossRef
Cancer has always been a severe threat to health and life. Since patients with advanced cancer often have a limited survival time and high treatment expenditures, routine therapies, such as surgery, radiation, and chemotherapy may help them live longer. However, the majority of these individuals cannot afford the excessive cost of care and have short life duration. With the introduction of oncolytic bacteria and viruses, a revolutionary therapeutic technique for the treatment and potential cure of malignant tumors has emerged. Clostridium, Bifidobacteria, Salmonella typhimurium, Listeria monocytogenes, and Bacillus are all oncolytic bacteria. Adenoviruses, Vaccinia viruses, Reoviruses, Herpesviruses, and Coxsackieviruses are all oncolytic viruses. This study aimed to review the current studies on the therapeutic potential of oncolytic bacteria and viruses as an alternate method for cancer prevention and therapy, including both experimental and clinical trials.
Title: Oncolytic Bacterial and Viral Therapies as Cancer Prevention and Treatment Options: A Comprehensive Review
Description:
Cancer has always been a severe threat to health and life.
Since patients with advanced cancer often have a limited survival time and high treatment expenditures, routine therapies, such as surgery, radiation, and chemotherapy may help them live longer.
However, the majority of these individuals cannot afford the excessive cost of care and have short life duration.
With the introduction of oncolytic bacteria and viruses, a revolutionary therapeutic technique for the treatment and potential cure of malignant tumors has emerged.
Clostridium, Bifidobacteria, Salmonella typhimurium, Listeria monocytogenes, and Bacillus are all oncolytic bacteria.
Adenoviruses, Vaccinia viruses, Reoviruses, Herpesviruses, and Coxsackieviruses are all oncolytic viruses.
This study aimed to review the current studies on the therapeutic potential of oncolytic bacteria and viruses as an alternate method for cancer prevention and therapy, including both experimental and clinical trials.
Related Results
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Abstract 4934: Immunostimulatory and oncolytic properties of rotavirus can overcome resistance to immune checkpoint blockade therapy
Abstract 4934: Immunostimulatory and oncolytic properties of rotavirus can overcome resistance to immune checkpoint blockade therapy
Abstract
Immune checkpoint targeted therapies against PD-1, PD-L1 and CTLA-4 are currently revolutionizing cancer care. However, only a minority of patients generate...
Abstract 1734: In vivo immunomodulatory effects by uPAR-retargeted oncolytic Measles virus
Abstract 1734: In vivo immunomodulatory effects by uPAR-retargeted oncolytic Measles virus
Abstract
Background: Oncolytic viruses offer an advantage over other treatment options, as they both induce cytotoxicity as well as immune modulation. Oncolytic meas...
Fusogenic Viruses in Oncolytic Immunotherapy
Fusogenic Viruses in Oncolytic Immunotherapy
Oncolytic viruses are under intense development and have earned their place among the novel class of cancer immunotherapeutics that are changing the face of cancer therapy. Their a...
Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma
Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma
Abstract
Malignant melanoma is aggressive cancer with a high rate of local invasiveness and metastasis. Currently, the treatment options for patients with advanced-stage an...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

